FDA Inspection 1098677 — Vitalant

Vitalant — FEI 1671454

The FDA completed an inspection of Vitalant on June 27, 2019 in Mcallen, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 27, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Mcallen, TX (United States)